Venturi Wealth Management LLC Has $1.33 Million Stock Position in Relx Plc $RELX

Venturi Wealth Management LLC boosted its position in shares of Relx Plc (NYSE:RELX) by 1.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 24,476 shares of the technology company’s stock after purchasing an additional 232 shares during the period. Venturi Wealth Management LLC’s holdings in Relx were worth $1,330,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Bleakley Financial Group LLC increased its stake in shares of Relx by 1.5% in the first quarter. Bleakley Financial Group LLC now owns 14,147 shares of the technology company’s stock worth $713,000 after purchasing an additional 207 shares during the period. Cynosure Group LLC increased its stake in shares of Relx by 3.5% in the first quarter. Cynosure Group LLC now owns 6,951 shares of the technology company’s stock worth $350,000 after purchasing an additional 236 shares during the period. Bridgewater Advisors Inc. increased its stake in shares of Relx by 2.1% in the first quarter. Bridgewater Advisors Inc. now owns 11,463 shares of the technology company’s stock worth $617,000 after purchasing an additional 238 shares during the period. Marks Group Wealth Management Inc increased its stake in shares of Relx by 1.0% in the second quarter. Marks Group Wealth Management Inc now owns 23,789 shares of the technology company’s stock worth $1,293,000 after purchasing an additional 243 shares during the period. Finally, UMB Bank n.a. increased its stake in shares of Relx by 19.1% in the second quarter. UMB Bank n.a. now owns 1,634 shares of the technology company’s stock worth $89,000 after purchasing an additional 262 shares during the period. 15.02% of the stock is currently owned by institutional investors.

Relx Stock Up 0.9%

NYSE RELX opened at $45.84 on Thursday. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. The stock’s 50 day moving average is $47.49 and its two-hundred day moving average is $50.87. The company has a market capitalization of $84.01 billion, a price-to-earnings ratio of 24.65, a PEG ratio of 2.96 and a beta of 0.87. Relx Plc has a 1-year low of $44.19 and a 1-year high of $56.33.

Relx Cuts Dividend

The business also recently disclosed a semi-annual dividend, which was paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th were issued a dividend of $0.2634 per share. This represents a yield of 170.0%. The ex-dividend date of this dividend was Friday, August 8th. Relx’s payout ratio is presently 28.49%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on RELX. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Kepler Capital Markets upgraded Relx from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 18th. Barclays restated an “overweight” rating on shares of Relx in a research note on Tuesday. Weiss Ratings restated a “buy (b)” rating on shares of Relx in a research note on Wednesday. Finally, Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy”.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.